세계의 의약품 위탁 연구 생산 (CRAM) 시장 (2023~2027) : CMO, CRO

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Service
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global pharmaceutical contract research and manufacturing (CRAM) market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 – 2021 ($ billion)
o 4.2 Service Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Service Segment 2017 – 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Service
o 6.1 Market segments
o Exhibit 30: Chart on Service – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Service – Market share 2022-2027 (%)
o 6.2 Comparison by Service
o Exhibit 32: Chart on Comparison by Service
o Exhibit 33: Data Table on Comparison by Service
o 6.3 CMO – Market size and forecast 2022-2027
o Exhibit 34: Chart on CMO – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on CMO – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on CMO – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on CMO – Year-over-year growth 2022-2027 (%)
o 6.4 CRO – Market size and forecast 2022-2027
o Exhibit 38: Chart on CRO – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on CRO – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on CRO – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on CRO – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Service
o Exhibit 42: Market opportunity by Service ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 45: Chart on Comparison by End-user
o Exhibit 46: Data Table on Comparison by End-user
o 7.3 Big pharmaceuticals – Market size and forecast 2022-2027
o Exhibit 47: Chart on Big pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Big pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Big pharmaceuticals – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Big pharmaceuticals – Year-over-year growth 2022-2027 (%)
o 7.4 Small and medium-sized pharmaceuticals – Market size and forecast 2022-2027
o Exhibit 51: Chart on Small and medium-sized pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Small and medium-sized pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Small and medium-sized pharmaceuticals – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Small and medium-sized pharmaceuticals – Year-over-year growth 2022-2027 (%)
o 7.5 Generic pharmaceuticals – Market size and forecast 2022-2027
o Exhibit 55: Chart on Generic pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 56: Data Table on Generic pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Chart on Generic pharmaceuticals – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Generic pharmaceuticals – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 59: Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 India – Market size and forecast 2022-2027
o Exhibit 85: Chart on India – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on India – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Almac Group Ltd.
o Exhibit 108: Almac Group Ltd. – Overview
o Exhibit 109: Almac Group Ltd. – Product / Service
o Exhibit 110: Almac Group Ltd. – Key offerings
o 12.4 Boehringer Ingelheim International GmbH
o Exhibit 111: Boehringer Ingelheim International GmbH – Overview
o Exhibit 112: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 113: Boehringer Ingelheim International GmbH – Key news
o Exhibit 114: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 115: Boehringer Ingelheim International GmbH – Segment focus
o 12.5 Cadila Pharmaceuticals Ltd.
o Exhibit 116: Cadila Pharmaceuticals Ltd. – Overview
o Exhibit 117: Cadila Pharmaceuticals Ltd. – Product / Service
o Exhibit 118: Cadila Pharmaceuticals Ltd. – Key offerings
o 12.6 Catalent Inc.
o Exhibit 119: Catalent Inc. – Overview
o Exhibit 120: Catalent Inc. – Business segments
o Exhibit 121: Catalent Inc. – Key news
o Exhibit 122: Catalent Inc. – Key offerings
o Exhibit 123: Catalent Inc. – Segment focus
o 12.7 Charles River Laboratories International Inc.
o Exhibit 124: Charles River Laboratories International Inc. – Overview
o Exhibit 125: Charles River Laboratories International Inc. – Business segments
o Exhibit 126: Charles River Laboratories International Inc. – Key news
o Exhibit 127: Charles River Laboratories International Inc. – Key offerings
o Exhibit 128: Charles River Laboratories International Inc. – Segment focus
o 12.8 Cmic Holdings Co. Ltd.
o Exhibit 129: Cmic Holdings Co. Ltd. – Overview
o Exhibit 130: Cmic Holdings Co. Ltd. – Business segments
o Exhibit 131: Cmic Holdings Co. Ltd. – Key offerings
o Exhibit 132: Cmic Holdings Co. Ltd. – Segment focus
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 133: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 134: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 135: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 136: Dr Reddys Laboratories Ltd. – Segment focus
o 12.10 ICON plc
o Exhibit 137: ICON plc – Overview
o Exhibit 138: ICON plc – Product / Service
o Exhibit 139: ICON plc – Key offerings
o 12.11 IQVIA Holdings Inc.
o Exhibit 140: IQVIA Holdings Inc. – Overview
o Exhibit 141: IQVIA Holdings Inc. – Business segments
o Exhibit 142: IQVIA Holdings Inc. – Key news
o Exhibit 143: IQVIA Holdings Inc. – Key offerings
o Exhibit 144: IQVIA Holdings Inc. – Segment focus
o 12.12 Laboratory Corp. of America Holdings
o Exhibit 145: Laboratory Corp. of America Holdings – Overview
o Exhibit 146: Laboratory Corp. of America Holdings – Business segments
o Exhibit 147: Laboratory Corp. of America Holdings – Key news
o Exhibit 148: Laboratory Corp. of America Holdings – Key offerings
o Exhibit 149: Laboratory Corp. of America Holdings – Segment focus
o 12.13 Lonza Group Ltd.
o Exhibit 150: Lonza Group Ltd. – Overview
o Exhibit 151: Lonza Group Ltd. – Business segments
o Exhibit 152: Lonza Group Ltd. – Key news
o Exhibit 153: Lonza Group Ltd. – Key offerings
o Exhibit 154: Lonza Group Ltd. – Segment focus
o 12.14 Lupin Ltd.
o Exhibit 155: Lupin Ltd. – Overview
o Exhibit 156: Lupin Ltd. – Product / Service
o Exhibit 157: Lupin Ltd. – Key news
o Exhibit 158: Lupin Ltd. – Key offerings
o 12.15 Recipharm AB
o Exhibit 159: Recipharm AB – Overview
o Exhibit 160: Recipharm AB – Business segments
o Exhibit 161: Recipharm AB – Key offerings
o Exhibit 162: Recipharm AB – Segment focus
o 12.16 Samsung Electronics Co. Ltd.
o Exhibit 163: Samsung Electronics Co. Ltd. – Overview
o Exhibit 164: Samsung Electronics Co. Ltd. – Business segments
o Exhibit 165: Samsung Electronics Co. Ltd. – Key news
o Exhibit 166: Samsung Electronics Co. Ltd. – Key offerings
o Exhibit 167: Samsung Electronics Co. Ltd. – Segment focus
o 12.17 Syneos Health Inc.
o Exhibit 168: Syneos Health Inc. – Overview
o Exhibit 169: Syneos Health Inc. – Business segments
o Exhibit 170: Syneos Health Inc. – Key offerings
o Exhibit 171: Syneos Health Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Service
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Service Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Service – Market share 2022-2027 (%)
Exhibits31: Data Table on Service – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Service
Exhibits33: Data Table on Comparison by Service
Exhibits34: Chart on CMO – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on CMO – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on CMO – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on CMO – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on CRO – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on CRO – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on CRO – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on CRO – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Service ($ billion)
Exhibits43: Chart on End-user – Market share 2022-2027 (%)
Exhibits44: Data Table on End-user – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Big pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Big pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Big pharmaceuticals – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Big pharmaceuticals – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Small and medium-sized pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Small and medium-sized pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Small and medium-sized pharmaceuticals – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Small and medium-sized pharmaceuticals – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Generic pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Generic pharmaceuticals – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Generic pharmaceuticals – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Generic pharmaceuticals – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ billion)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on India – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on India – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ billion)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Almac Group Ltd. – Overview
Exhibits109: Almac Group Ltd. – Product / Service
Exhibits110: Almac Group Ltd. – Key offerings
Exhibits111: Boehringer Ingelheim International GmbH – Overview
Exhibits112: Boehringer Ingelheim International GmbH – Business segments
Exhibits113: Boehringer Ingelheim International GmbH – Key news
Exhibits114: Boehringer Ingelheim International GmbH – Key offerings
Exhibits115: Boehringer Ingelheim International GmbH – Segment focus
Exhibits116: Cadila Pharmaceuticals Ltd. – Overview
Exhibits117: Cadila Pharmaceuticals Ltd. – Product / Service
Exhibits118: Cadila Pharmaceuticals Ltd. – Key offerings
Exhibits119: Catalent Inc. – Overview
Exhibits120: Catalent Inc. – Business segments
Exhibits121: Catalent Inc. – Key news
Exhibits122: Catalent Inc. – Key offerings
Exhibits123: Catalent Inc. – Segment focus
Exhibits124: Charles River Laboratories International Inc. – Overview
Exhibits125: Charles River Laboratories International Inc. – Business segments
Exhibits126: Charles River Laboratories International Inc. – Key news
Exhibits127: Charles River Laboratories International Inc. – Key offerings
Exhibits128: Charles River Laboratories International Inc. – Segment focus
Exhibits129: Cmic Holdings Co. Ltd. – Overview
Exhibits130: Cmic Holdings Co. Ltd. – Business segments
Exhibits131: Cmic Holdings Co. Ltd. – Key offerings
Exhibits132: Cmic Holdings Co. Ltd. – Segment focus
Exhibits133: Dr Reddys Laboratories Ltd. – Overview
Exhibits134: Dr Reddys Laboratories Ltd. – Business segments
Exhibits135: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits136: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits137: ICON plc – Overview
Exhibits138: ICON plc – Product / Service
Exhibits139: ICON plc – Key offerings
Exhibits140: IQVIA Holdings Inc. – Overview
Exhibits141: IQVIA Holdings Inc. – Business segments
Exhibits142: IQVIA Holdings Inc. – Key news
Exhibits143: IQVIA Holdings Inc. – Key offerings
Exhibits144: IQVIA Holdings Inc. – Segment focus
Exhibits145: Laboratory Corp. of America Holdings – Overview
Exhibits146: Laboratory Corp. of America Holdings – Business segments
Exhibits147: Laboratory Corp. of America Holdings – Key news
Exhibits148: Laboratory Corp. of America Holdings – Key offerings
Exhibits149: Laboratory Corp. of America Holdings – Segment focus
Exhibits150: Lonza Group Ltd. – Overview
Exhibits151: Lonza Group Ltd. – Business segments
Exhibits152: Lonza Group Ltd. – Key news
Exhibits153: Lonza Group Ltd. – Key offerings
Exhibits154: Lonza Group Ltd. – Segment focus
Exhibits155: Lupin Ltd. – Overview
Exhibits156: Lupin Ltd. – Product / Service
Exhibits157: Lupin Ltd. – Key news
Exhibits158: Lupin Ltd. – Key offerings
Exhibits159: Recipharm AB – Overview
Exhibits160: Recipharm AB – Business segments
Exhibits161: Recipharm AB – Key offerings
Exhibits162: Recipharm AB – Segment focus
Exhibits163: Samsung Electronics Co. Ltd. – Overview
Exhibits164: Samsung Electronics Co. Ltd. – Business segments
Exhibits165: Samsung Electronics Co. Ltd. – Key news
Exhibits166: Samsung Electronics Co. Ltd. – Key offerings
Exhibits167: Samsung Electronics Co. Ltd. – Segment focus
Exhibits168: Syneos Health Inc. – Overview
Exhibits169: Syneos Health Inc. – Business segments
Exhibits170: Syneos Health Inc. – Key offerings
Exhibits171: Syneos Health Inc. – Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations